MONTGOMERY, TEXAS -- (MARKET WIRE) -- March 27, 2007 -- Metabolic Research, Inc. (OTCBB: MTBR) announced today the Company’s restructuring into two divisions. The Nutraceutical Division will continue the Company’s mandate to acquire or develop and market “nutraceutical” products, and the Pharmaceutical Division will research and develop new pharmaceutical drugs.
